Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

NIH launches pregnancy registry to monitor research product safety

NCT ID NCT04977466

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study creates a pregnancy registry for people who took part in NIH clinical trials and became pregnant during or within one year after the study. Researchers will collect health and birth information through interviews and medical records to monitor outcomes after unplanned exposure to research products. No treatment is given; the goal is to gather safety data.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2023

Expected to finish

Dec 2045

An estimate. End dates often move.

Lead sponsor

A government research agency

The lead sponsor is the US National Institutes of Health.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants of NIH IRP protocols.

Ages

1 day to 100 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: * All Participants * Able and willing to provide written informed consent for study participation. * Stated willingness to comply with all data collection study activities * Male or female, aged 0-100 years * Participant or partner of a participant on NIH protocol * Group #1 (Pregnant Female NIH Participants) Female NIH study participants with a confirmed pregnancy that occurred during or within 1 year after the last day of intervention during participation in NIH intramural clinical trials AND that meet at least one of the following criteria/assessments: * Positive pregnancy test (serum or urine) * Auscultation of fetal heart tones * Clinical assessment of fetal movement * Demonstration of pregnancy by ultrasound * Group #2 (Male and Female Partners) Male or female partners of women who participated in NIH intramural clinical trials and that became pregnant while they were on study or within 1 year of the last day of intervention. -Group #3 (Pregnant Female Partners of Male or Female NIH Clinical Trial Participants) Female partners of NIH intramural clinical trial participants who became pregnant while their partner was or within 1 year after the last day of intervention after their partner was on a study AND who meet at least one of the following criteria/assessments: * Positive pregnancy test (serum or urine) * Auscultation of fetal heart tones * Clinical assessment of fetal movement * Demonstration of pregnancy by ultrasound * Group #4 (Neonate or Offspring of a Pregnant Female Participant or Pregnant Female Partner) Offspring from birth to 12 months of age and born to: * Females who participated in an NIH intramural clinical trial and became pregnant while on study or within 1 year after. * Female partners of women or men who participated in an NIH intramural clinical trial who became pregnant while they were on study or within 1 year after. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: * Participation in NIH research studies that do not meet criteria of a clinical trial, such as natural history or observational studies * Pregnancy that occurs/occurred more than 1 year after NIH clinical trial participation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pregnancy outcome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.